Nathalie Degardin

Nathalie Degardin

Auto-generated profile, based on publicly available information

Nathalie Degardin

Service de Chirurgie Plastique Reparatrice, Hopital de la Timone Enfants, Marseille, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
TBT. Busa
T. Busa
MMM. Milh
M. Milh
NDN. Degardin
N. Degardin
NGN. Girard
N. Girard
SSS. Sigaudy
S. Sigaudy
NPN. Philip
N. Philip

1 September 2016 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
ADA. Dabadie
A. Dabadie
EQE. Quarello
E. Quarello
NDN. Degardin
N. Degardin
RDR. Desbriere
R. Desbriere
HHH. Heckenroth
H. Heckenroth
GGG. Gorincour
G. Gorincour

23 April 2020 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
PDF file
NCNeus Calbet-Llopart
Neus Calbet-Llopart
MPMirella Pascini‐Garrigos
Mirella Pascini‐Garrigos
GTGemma Tell‐Martí
Gemma Tell‐Martí
MPMiriam Potrony
Miriam Potrony
VSVanessa Martins da Silva
Vanessa Martins da Silva
JBJoan Anton Puig Butillé
Joan Anton Puig Butillé

1 February 2012 in Annales de Chirurgie Plastique Esthétique
Verified
Journal Article
Closed access
CBC. Bartolin
C. Bartolin
GMG. Magalon
G. Magalon
YJY. Jallut
Y. Jallut
CBC. Bouvattier
C. Bouvattier
DCD. Casanova
D. Casanova
NDN. Degardin
N. Degardin

15 April 2026 in iScience
Verified
Journal Article
Open access
AWAxelle Wilmerding
Axelle Wilmerding
ARAurélie Richard
Aurélie Richard
NMNicolas Macagno
Nicolas Macagno
EHEstelle Hirsinger
Estelle Hirsinger
TGTarek Gharsalli
Tarek Gharsalli
MDMarie-Claire DELFINI
Marie-Claire DELFINI
Multinucleation in cancer has been shown to promote aneuploidy, which correlates with tumor aggressiveness. This is particularly true for melanoma, a cancer caused by excessive proliferation of melanocytes, whose RAS/ERK pathway is overactivated. Using single-nucleus RNA sequencing after overactivation of the RAS/ERK pathway in the chicken embryo as an in vivo model, we discovered that RIPOR2 is a positive transcriptional target of this pathway, including in melanocyte precursors. Similar transcriptional control of RIPOR2 by RAS/ERK is conserved in human melanoma cells. RIPOR2 emerged as an attractive target because it encodes an atypical RHOA inhibitory protein involved in the development of physiologically multinucleated cell types. We found that RIPOR2 is ectopically expressed in human melanoma and functionally promotes multinucleation in both an animal model and human tumor-derived cells, including melanoma cell lines. Our results suggest that RIPOR2 expression, downstream of RAS/ERK overactivation, may contribute to melanocyte transformation by promoting multinucleation.

9 November 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
DADaniel Aldea
Daniel Aldea
NMNicolas Macagno
Nicolas Macagno
EMElise Marechal
Elise Marechal
MMMathias Moreno
Mathias Moreno
PRPauline Romanet
Pauline Romanet
Heather EtcheversHeather Etchevers
Heather Etchevers